Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
Yueren Zhao,1–3 Taro Kishi,1 Nakao Iwata,1 Manabu Ikeda3,4 1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; 2Department of Psychiatry, Okehazama Hospital Fujita Kokoro Care Center, Toyoake, Aichi, Japan; 3Department of Neuropsychiatry, Graduate...
Guardado en:
Autores principales: | Zhao Y, Kishi T, Iwata N, Ikeda M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1df274f946db4807bad1c0676f92fe23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louzã M, et al.
Publicado: (2011) -
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs L, et al.
Publicado: (2013) -
Risperidone long-acting injection: a review of its long term safety and efficacy
por: Michael K Rainer
Publicado: (2008) -
Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
por: Mario Louzã, et al.
Publicado: (2010) -
Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
por: Wissam El-Hage, et al.
Publicado: (2010)